CABOSUN trial of cabozantinib - could it change how we treat frontline RCC?
FALCON trial of fulvestrant for advanced breast cancer: subgroup analysis and overall survival
Overview of RAPIDO trial in rectal cancer and FOxTROT trial in colon cancer
The impact of p53 mutation on survival in EGFR-mutated NSCLC patients
Neoadjuvant therapy with trametinib and dabrafenib in high risk resectable BRAF-mutant melanoma
Rodabe N. Amaria